Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Gold

Showing results (181-190 of 703) with videos related to

Pageof 71
Sort By:
Therapeutic Advances in Neurological Disorders|April 7, 2017
Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatmentGisa Ellrichmann, Ralf Gold, Ilya Ayzenberg, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 21, 2017
Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential TremorDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Frontiers in Neurology|November 22, 2019
Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics StudyRuth Schneider, Erhan Genç, Christian Ahlborn, et al.
Journal of Neuroimmunology|July 10, 2014
Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritisKalliopi Pitarokoili, Björn Ambrosius, Lisa Schrewe, et al.
Frontiers in Neurology|August 23, 2018
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease PatientsDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Robert Hoepner, Carsten Lukas, et al.
Plos One|December 7, 2007
Time processing in Huntington's disease: a group-control studyChristian Beste, Carsten Saft, Jürgen Andrich, et al.
Immunity, Inflammation and Disease|June 2, 2015
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled studyMariusz Stasiolek, Ralf A Linker, Liat Hayardeny, et al.
Multiple Sclerosis and Related Disorders|July 30, 2018
Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous systemThomas Grüter, Ilya Ayzenberg, Anna Gahlen, et al.
Clinical Neuropharmacology|November 17, 2010
Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case reportAlexandra Schroeder, Ralf A Linker, Carsten Lukas, et al.
Pageof 71

Showing results (181-190 of 703) with videos related to

Sort By:
Pageof 71
Therapeutic Advances in Neurological Disorders|April 7, 2017
Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatmentGisa Ellrichmann, Ralf Gold, Ilya Ayzenberg, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 21, 2017
Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential TremorDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Frontiers in Neurology|November 22, 2019
Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics StudyRuth Schneider, Erhan Genç, Christian Ahlborn, et al.
Journal of Neuroimmunology|July 10, 2014
Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritisKalliopi Pitarokoili, Björn Ambrosius, Lisa Schrewe, et al.
Frontiers in Neurology|August 23, 2018
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease PatientsDaniel Richter, Dirk Woitalla, Siegfried Muhlack, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Robert Hoepner, Carsten Lukas, et al.
Plos One|December 7, 2007
Time processing in Huntington's disease: a group-control studyChristian Beste, Carsten Saft, Jürgen Andrich, et al.
Immunity, Inflammation and Disease|June 2, 2015
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled studyMariusz Stasiolek, Ralf A Linker, Liat Hayardeny, et al.
Multiple Sclerosis and Related Disorders|July 30, 2018
Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous systemThomas Grüter, Ilya Ayzenberg, Anna Gahlen, et al.
Clinical Neuropharmacology|November 17, 2010
Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case reportAlexandra Schroeder, Ralf A Linker, Carsten Lukas, et al.
Pageof 71